Company News
Biocon Pharma Receives US FDA Dapagliflozin Approval
Biocon Pharma Limited receives US FDA approval for Dapagliflozin Tablets 5mg and 10mg for type 2 diabetes treatment.
Approval strengthens Biocon's diabetes portfolio including oral formulations, biosi
